Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
113,177,462
-
Total 13F shares
-
769,601
-
Share change
-
+149,913
-
Total reported value
-
$1,124,000
-
Price per share
-
$1.46
-
Number of holders
-
10
-
Value change
-
+$226,915
-
Number of buys
-
6
-
Number of sells
-
1
Institutional Holders of Viking Therapeutics, Inc. - COMMON STOCK (VKTX) as of Q1 2017
As of 31 Mar 2017,
Viking Therapeutics, Inc. - COMMON STOCK (VKTX) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
769,601 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, GRT CAPITAL PARTNERS L.L.C., GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, Acrospire Investment Management LLC, UBS Group AG, MANUFACTURERS LIFE INSURANCE COMPANY, THE, REILLY FINANCIAL ADVISORS, LLC, and BlackRock Inc..
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.